Fintel reports that on October 21, 2024, EF Hutton initiated coverage of NRx Pharmaceuticals (NasdaqCM:NRXP) with a Buy ...

This was demonstrated during the 1988 US Presidential Election campaign, when the two candidates for vice-president, Senator Dan Quayle for the Republicans and Senator Lloyd Bentsen for the ...

The FTSE Russell, a leading global index provider, announced today the inclusion of Mankind Pharma and Nexus Select Trust in its various equity indices as part of the December ...

Leerink Partners has recently resumed MannKind Corp (MNKD) stock to Outperform rating, as announced on September 9, 2024, according to Finviz. Earlier, on June 13, 2024, Rodman & Renshaw had initiated ...

Year-to-Date Revenue: $139 million, a 55% increase over the prior year period. MannKind Corp (NASDAQ:MNKD) reported record revenue of $72 million for the second quarter of 2024, marking a 49% increase ...

A monument honoring the first Hispanic woman in space is the next project of a Southern California filmmaker. Steven C. Barber, who has been creating statues of America’s greatest explorers and ...

Warning! GuruFocus has detected 8 Warning Signs with MNKD. MannKind Corp (NASDAQ:MNKD) reported record revenue of $72 million for the second quarter of 2024, marking a 49% increase compared to the ...

India's fourth largest drugmaker by domestic sales, Mankind Pharma , has engaged investment banks Kotak Mahindra Capital and IIFL Capital as it looks to launch a QIP (qualified institutional ...

India's primary markets have witnessed a surge in growth this year, with 118 companies debuting through initial public offerings (IPOs). BSE data shows that 62 mainline IPOs, and 56 BSE SME IPOs have ...

MannKind (MNKD), which belongs to the Zacks Medical - Biomedical and Genetics industry, could be a great candidate to consider. This biopharmaceutical company has seen a nice streak of beating ...